Reconciliation of operating income (loss) and operating margin GAAP operating loss $ (4,466) $ (8,314) $ (20,306) $ (29,836) Stock-based compensation expense 5,635 7,370 21,065 21,956 Amortization of acquired intangibles 120 120 359 434 Restructuring (c) -- 5 -- 973 Facility exit and transition costs ((b) () -- -- -- 154 War related costs(d) -- -- 22 -- ----------- ----------- ----------- ----------- Non-GAAP operating income (loss) $ 1,289 $ (819) $ 1,140 $ (6,319) =========== =========== =========== =========== GAAP operating margin (10)% (19)% (15)% (23)% Non-GAAP operating margin 3% (2)% 1% (5)% Reconciliation of net loss GAAP net loss attributable to common stockholders $ (3,610) $ (10,726) $ (24,710) $ (34,299) Stock-based compensation expense 5,635 7,370 21,065 21,956 Amortization of acquired intangibles 120 120 359 434 Restructuring (c) -- 5 -- 973 Facility exit and transition costs ((b) () -- -- -- 154 War related costs(d) -- -- 22 -- Non-GAAP net income (loss) attributable to common stockholders $ 2,145 $ (3,231) $ (3,264) $ (10,782) =========== =========== =========== =========== Non-GAAP net income (loss) per share - basic and diluted $ 0.01 $ (0.02) $ (0.02) $ (0.08) =========== =========== =========== =========== Shares used in non-GAAP per share calculations: GAAP weighted-average shares used to compute net income per share - basic and diluted 149,306,274 139,186,364 147,074,320 137,033,800 Weighted average number of ordinary shares outstanding used in computing basic and diluted net loss per share (non-GAAP) 149,306,274 139,186,364 147,074,320 137,033,800 =========== =========== =========== ===========
Adjusted EBITDA (U.S. dollars in thousands)
Three Months Ended Nine Months Ended September 30, September 30, 2024 2023 2024 2023 ------ ------- ------- ------- Net loss $(3,610) $(10,726) $(24,710) $(34,299) Financial expenses (income), net (a) (2,160) (95) (1,672) (3,047) Provision for income taxes 1,304 2,507 6,076 7,510 Depreciation and amortization 1,254 1,248 3,834 3,409 ------ ------- ------- ------- EBITDA (3,212) (7,066) (16,472) (26,427) Non-cash stock-based compensation expense 5,635 7,370 21,065 21,956 Facility exit and transition costs (b) -- -- -- 154 Restructuring (c) -- 5 -- 973 War related costs (d) -- -- 22 -- ------ ------- ------- ------- Adjusted EBITDA $ 2,423 $ 309 $ 4,615 $ (3,344) ====== ======= ======= ======= (a) The three months ended September 30, 2024 and 2023, and the nine months ended September 30, 2024, and 2023, include $725, $789, $2,131 and $2,400 respectively, of interest expenses. (b) Facility exit and transition costs for the nine months ended September 30, 2023, include losses from sale of fixed assets and other costs associated with moving to our temporary office in Israel. (c) The three and nine months ended September 30, 2023 include one-time employee termination benefits incurred in connection with the 2023 Reorganization Plan and the 2022 Restructuring Plan. (d) The nine months ended September 30, 2024 include costs related to conflicts in Israel, attributable to temporary relocation of key employees from Israel for business continuity purposes, purchase of emergency equipment for key employees for business continuity purposes, and charitable donation to communities directly impacted by the war.
Reported KPIs
As of September 30, 2024 2023 --- ---------------- --------------- (U.S. dollars, amounts in thousands) ------------------------------------------ Annualized Recurring Revenue $ 168,879 $ 163,069 Remaining Performance Obligations $ 187,846 $ 163,995 Three Months Ended September 30, 2024 2023 ----------- ------ ---------- ----- Net Dollar Retention Rate 101% 101%
(END) Dow Jones Newswires
November 06, 2024 07:00 ET (12:00 GMT)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.